共 13 条
[1]
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J] . Sumio Watanabe,Etsuko Hashimoto,Kenichi Ikejima,Hirofumi Uto,Masafumi Ono,Yoshio Sumida,Masataka Seike,Yoshiyuki Takei,Tetsuo Takehara,Katsutoshi Tokushige,Atsushi Nakajima,Masashi Yoneda,Toshiji Saibara,Goshi Shiota,Isao Sakaida,Makoto Nakamuta,Toshihiko Mizuta,Hirohito Tsubouchi,Kentaro Sugano,Tooru Shimosegawa.Hepatol Res . 2015 (4)
[2]
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology[J] . Naga Chalasani,Zobair Younossi,Joel E. Lavine,Anna Mae Diehl,Elizabeth M. Brunt,Kenneth Cusi,Michael Charlton,Arun J. Sanyal.Gastroenterology . 2012 (7)
[3]
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study[J] . Yuichiro Eguchi,Hideyuki Hyogo,Masafumi Ono,Toshihiko Mizuta,Naofumi Ono,Kazuma Fujimoto,Kazuaki Chayama,Toshiji Saibara.Journal of Gastroenterology . 2012 (5)
[4]
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis[J] . Herbert Tilg,Alexander R. Moschen.Hepatology . 2010 (5)
[5]
Epidemiology of non-alcoholic fatty liver disease in China[J] . Jian-Gao Fan,Geoffrey C. Farrell.Journal of Hepatology . 2008 (1)
[6]
Review article: epidemiology, pathogenesis and potential treatments of paediatric non‐alcoholic fatty liver disease[J] . N. J.BARSHOP,C. B.SIRLIN,J. B.SCHWIMMER,J. E.LAVINE.Alimentary Pharmacology & Therapeutics . 2008 (1)
[7]
Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients[J] . GiovanniTargher,MartinaMontagnana,GianlucaSalvagno,PaoloMoghetti,GiacomoZoppini,MicheleMuggeo,GiuseppeLippi.Clinical Endocrinology . 2007 (3)